Artificial Intelligence: A promising tool in diagnosis of respiratory diseases

Abstract

Respiratory diseases (RD) are a major healthcare issue and is predicted to be leading cause of mortality by 2030. Artificial intelligence (AI) has been recently gained interest -in scientific fields. Among a variety of application, it has made a marked embrace in medical domain where it is applied for diagnosis and disease progression by clinicians. Further, in particular, AI based Machine learning (ML) and Deep Learning (DL) algorithms have come up as an effective emerging trend in diagnosis of respiratory diseases. These algorithms are trained to classify the respiratory diseases such as pneumonia, fibrosis, cancer, tuberculosis emphysema, asthma based on radiographs, CT scans etc. images. The AI enabled diagnosis can facilitate precise diagnosis and differentiation among over-lapping characteristics bearing lung diseases. This review focuses on the AI-based algorithms assisted, improved diagnosis of three respiratory diseases specifically COPD (Chronic obstructive pulmonary disease), asthma and lung fibrosis. Further, AI is expected to play a crucial role in facilitating diagnosis aiding clinicians in predicting and management of lung diseases taking it towards a promising tool for everyday clinical practice soon. It is written with a hope that this brief review of emphasizing utilization of AI in medical field will be helpful to clinicians.

Keywords

Artificial intelligence / Deep learning / Diagnosis / Machine learning / Respiratory diseases / COPD

References

[1] Organization WH. Practical Approach to Lung Health: Manual Initiating Pal Implementation. 2008.

[2] Reeves RM, Hardelid P, Gilbert R, et al. Estimating the Burden of Respiratory Syncytial Virus (Rsv) on Respiratory Hospital Admissions in Children Less than Five Years of Age in England. vol. 11. 2017:122–129, 2007-2012.

[3] Luo MX, Hua S, Shang QY. Application of nanotechnology in drug delivery systems for respiratory diseases. Mol Med Rep. 2021 May 1;23(5):1–7.

[4] McBee MP, Awan OA, Colucci AT, et al. Deep learning in radiology. Acad Radiol. 2018;25:1472–1480.

[5] Gonem S, Janssens W, Das N, Topalovic M. Applications of artificial intelligence and machine learning in respiratory medicine. Thorax. 2020;75:695–701.

[6] Choudhury S, Chohan A, Dadhwal R, Vakil AP, Franco R, Taweesedt PT. Applications of artificial intelligence in common pulmonary diseases. Artificial Intelligence in Medical Imaging. 2022;3:1–7.

[7] Rajkomar A, Dean J, Kohane I. Machine learning in medicine. N Engl J Med. 2019;380:1347–1358.

[8] Erickson BJ, Korfiatis P, Akkus Z, Kline TL. Machine learning for medical imaging. Radiographics. 2017;37:505–515.

[9] Feng Y, Wang Y, Zeng C, Mao H. Artificial intelligence and machine learning in chronic airway diseases: focus on asthma and chronic obstructive pulmonary disease. Int J Med Sci. 2021;18:2871.

[10] Wang L. Deep learning techniques to diagnose lung cancer. Cancers. 2022;14.

[11] Fischer AM, Varga-Szemes A, van Assen M, et al. Comparison of Artificial Intelligence-Based Fully Automatic Chest Ct Emphysema Quantification to Pulmonary Function Testing. vol. 214. 2020:1065–1071.

[12] Fischer AM, Varga-Szemes A, Martin SS, et al. Artificial intelligence-based fully automated per lobe segmentation and emphysema-quantification based on chest computed tomography compared with global initiative for chronic obstructive lung disease severity of smokers. 2020;35:S28–S34.

[13] Fernandez-Granero MA, Sanchez-Morillo D, Leon-Jimenez AJB, Equipment B. An artificial intelligence approach to early predict symptom-based exacerbations of copd. 2018;32:778–784.

[14] Ebrahimian S, Digumarthy SR, Bizzo B, et al. Artificial Intelligence Has Similar Performance to Subjective Assessment of Emphysema Severity on Chest Ct. vol. 29. 2022:1189–1195.

[15] Wang L, Li G, Ezeana CF, et al. An ai-driven clinical care pathway to reduce 30-day readmission for chronic obstructive pulmonary disease (copd) patients. Sci Rep. 2022;12:20633.

[16] Li M, Cheng K, Ku K, Li J, Hu H, Ung COL. Modelling 30-day hospital readmission after discharge for copd patients based on electronic health records. NPJ Primary Care Respiratory Medicine. 2023;33:16.

[17] Chu SH, Wan ES, Cho MH, et al. An independently validated, portable algorithm for the rapid identification of copd patients using electronic health records. Sci Rep. 2021;11:19959.

[18] Shah SA, Nwaru BI, Sheikh A, Simpson CR, Kotz D. Development and validation of a multivariable mortality risk prediction model for copd in primary care. NPJ primary care respiratory medicine. 2022;32:21.

[19] Lin S, Zhang Q, Chen F, Luo L, Chen L, Zhang W. Smooth bayesian network model for the prediction of future high-cost patients with copd. Int J Med Inf. 2019;126:147–155.

[20] Goto T, Camargo Jr CA, Faridi MK, Yun BJ, Hasegawa K. Machine learning approaches for predicting disposition of asthma and copd exacerbations in the ed. Am J Emerg Med. 2018;36:1650–1654.

[21] Amaral JL, Lopes AJ, Faria AC, Melo PL. Machine learning algorithms and forced oscillation measurements to categorise the airway obstruction severity in chronic obstructive pulmonary disease. Comput Methods Progr Biomed. 2015;118:186–197.

[22] Joumaa H, Sigogne R, Maravic M, Perray L, Bourdin A, Roche N. Artificial intelligence to differentiate asthma from copd in medico-administrative databases. BMC Pulm Med. 2022;22:1–9.

[23] Selroos O, Kupczyk M, Kuna P, et al. National and regional asthma programmes in europe. Eur Respir Rev. 2015;24:474–483.

[24] Aaron SD, Boulet LP, Reddel HK, Gershon AS. Underdiagnosis and overdiagnosis of asthma. Am J Respir Crit Care Med. 2018;198:1012–1020.

[25] Exarchos KP, Beltsiou M, Votti C-A, Kostikas K. Artificial intelligence techniques in asthma: a systematic review and critical appraisal of the existing literature. Eur Respir J. 2020;56.

[26] Seol HY, Shrestha P, Muth JF, et al. Artificial intelligence-assisted clinical decision support for childhood asthma management: a randomized clinical trial. PLoS One. 2021;16:e0255261.

[27] Yu G, Li Z, Li S, et al. The role of artificial intelligence in identifying asthma in pediatric inpatient setting. Ann Transl Med. 2020;8.

[28] Tomita K, Nagao R, Touge H, et al. Deep learning facilitates the diagnosis of adult asthma. Allergol Int. 2019;68:456–461.

[29] Hui CY, McKinstry B, Fulton O, Buchner M, Pinnock H. Patients’ and clinicians’ perceived trust in internet-of-things systems to support asthma self-management: qualitative interview study. JMIR mHealth and uHealth. 2021;9:e24127.

[30] Hafke-Dys H, Kuźnar-Kamińska B, Grzywalski T, Maciaszek A, Szarzyński K, Kociński J. Artificial intelligence approach to the monitoring of respiratory sounds in asthmatic patients. Front Physiol. 2021;12:1980.

[31] Zhang G, Luo L, Zhang L, Liu Z. Research progress of respiratory disease and idiopathic pulmonary fibrosis based on artificial intelligence. Diagnostics. 2023;13:357.

[32] Handa T, Tanizawa K, Oguma T, et al. Novel artificial intelligence-based technology for chest computed tomography analysis of idiopathic pulmonary fibrosis. Annals of the American Thoracic Society. 2022;19:399–406.

[33] Nishiyama O, Taniguchi H, Kondoh Y, et al. A simple assessment of dyspnoea as a prognostic indicator in idiopathic pulmonary fibrosis. Eur Respir J. 2010;36:1067–1072.

[34] Ley B, Ryerson CJ, Vittinghoff E, et al. A multidimensional index and staging system for idiopathic pulmonary fibrosis. Ann Intern Med. 2012;156:684–691.

[35] Mäkelä K, Mäyränpää MI, Sihvo H-K, et al. Artificial intelligence identifies inflammation and confirms fibroblast foci as prognostic tissue biomarkers in idiopathic pulmonary fibrosis. Hum Pathol. 2021;107:58–68.

[36] Wu X, Yin C, Chen X, et al. Idiopathic pulmonary fibrosis mortality risk prediction based on artificial intelligence: the ctpf model. Front Pharmacol. 2022;13:878764.

[37] Furukawa T, Oyama S, Yokota H, et al. A comprehensible machine learning tool to differentially diagnose idiopathic pulmonary fibrosis from other chronic interstitial lung diseases. Respirology. 2022;27:739–746.

[38] Wong A, Lu J, Dorfman A, et al. Fibrosis-net: a tailored deep convolutional neural network design for prediction of pulmonary fibrosis progression from chest ct images. Frontiers in artificial intelligence. 2021;4:764047.

[39] Balasubramaniam S, Satheesh Kumar K. Optimal ensemble learning model for covid-19 detection using chest x-ray images. Biomed Signal Process Control. 2023;81:104392.

[40] Choudhury A, Balasubramaniam S, Kumar AP, Kumar SNP. Psso: political squirrel search optimizer-driven deep learning for severity level detection and classification of lung cancer. Int J Inf Technol Decis Making. 2023:1–34.

[41] Escalante HJ, Montes-y-Gómez M, González JA, et al. Acute leukemia classification by ensemble particle swarm model selection. Artif Intell Med. 2012;55:163–175.

[42] Mudgal SK, Agarwal R, Chaturvedi J, Gaur R, Ranjan N. Real-world application, challenges and implication of artificial intelligence in healthcare: an essay. Pan Afr Med J. 2022;43:3.

[43] George AS, George AH, Shahul A, Baskar T. Ai-driven breakthroughs in healthcare: google health’s advances and the future of medical ai. Partners Universal International Innovation Journal. 2023;1:256–267.

RIGHTS & PERMISSIONS

2024 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.